| Literature DB >> 24895493 |
Vijay Kumar Chityala1, K Sathish Kumar1, Ramesh Macha2, Parthasarathy Tigulla2.
Abstract
Novel mixed ligand bivalentEntities:
Year: 2014 PMID: 24895493 PMCID: PMC4034397 DOI: 10.1155/2014/691260
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1Schematic routes of the synthesis of the complexes.
Analytical data of Schiff bases and their metal complexes.
| Compound | Formula | M.Wt. | C | H | N | O | M |
|---|---|---|---|---|---|---|---|
| DMIIMBP | C12H11BrN2O2 | 296 | 48.76 (48.84) | 3.58 (3.76) | 9.34 (9.49) | 10.54 (10.84) | — |
| [Cu(DMIIMBP)(phen)ClO4] | C24H20BrClCuN4O6 | 637 | 44.69 (45.09) | 3.11 (3.15) | 8.46 (8.76) | 14.81 (15.01) | 9.89 (9.94) |
| [Cu(DMIIMBP)(bipy)ClO4] | C22H20BrClCuN4O6 | 613 | 42.33 (42.94) | 3.17 (3.28) | 8.94 (9.11) | 15.14 (15.60) | 10.18 (10.33) |
| [Cu(DMIIMBP)(oxine)] | C21H18BrCuN3O3 | 502 | 49.25 (50.06) | 3.34 (3.60) | 8.27 (8.34) | 9.24 (9.53) | 12.53 (12.61) |
| [Cu(DMIIMBP)(5-Cl-oxine)] | C21H17BrClCuN3O3 | 536 | 46.01 (46.86) | 3.09 (3.18) | 7.92 (7.81) | 8.65 (8.92) | 11.02 (11.81) |
| DMIIMCP | C12H11ClN2O2 | 250 | 57.05 (57.49) | 4.34 (4.42) | 11.07 (11.17) | 12.24 (12.76) | — |
| [Cu(DMIIMCP)(phen)ClO4] | C24H20Cl2CuN4O6 | 593 | 55.10 (55.46) | 3.21 (3.39) | 8.99 (9.42) | 15.26 (16.14) | 10.13 (10.68) |
| [Cu(DMIIMCP)(bipy)ClO4] | C22H20Cl2CuN4O6 | 569 | 41.98 (46.29) | 3.05 (3.53) | 9.14 (9.81) | 15.95 (16.82) | 10.82 (11.13) |
| [Cu(DMIIMCP)(oxine)] | C21H18ClCuN3O3 | 458 | 54.89 (54.90) | 3.85 (3.95) | 9.10 (9.15) | 10.26 (10.45) | 12.99 (13.83) |
| [Cu(DMIIMCP)(5-Cl-oxine)] | C21H17Cl2CuN3O3 | 492 | 50.99 (51.08) | 3.19 (3.47) | 8.14 (8.51) | 9.11 (9.72) | 12.67 (12.87) |
Some important IR absorption frequencies (cm−1) of Schiff bases and metal complexes.
| Compound |
|
|
|
|
| Other bands |
|---|---|---|---|---|---|---|
| DMIIMBP | 3446 | 1641 | 1182 | — | — |
|
| [Cu(DMIIMBP)(phen)ClO4] | — | 1620 | 1164 | 550 | 448 |
|
| [Cu(DMIIMBP)(bipy)ClO4] | — | 1614 | 1162 | 548 | 445 |
|
| [Cu(DMIIMBP)(oxine)] | — | 1607 | 1167 and 1113 | 550 | 410 | — |
| [Cu(DMIIMBP)(5-Cl-oxine)] | — | 1618 | 1159 and 1133 | 543 | 454 |
|
| DMIIMCP | 3453 | 1605 | 1183 | — | — |
|
| [Cu(DMIIMCP)(phen)ClO4] | — | 1622 | 1164 | 552 | 434 |
|
| [Cu(DMIIMCP)(bipy)ClO4] | — | 1618 | 1162 | 550 | 419 |
|
| [Cu(DMIIMCP)(oxine)] | — | 1609 | 1189 and 1109 | 521 | 414 | — |
| [Cu(DMIIMCP)(5-Cl-oxine)] | — | 1633 | 1183 and 1128 | 549 | 421 |
|
Figure 1(a) The TGA spectrum of [Cu(DMIIMBP)(phen)ClO4]. (b) The TGA spectrum of [Cu(DMIIMCP)(oxine)].
Electronic spectral data and magnetic susceptibility values of the Cu(II) complexes.
| Complex | Wave number ( |
|
|
|---|---|---|---|
| [Cu(DMIIMBP)(phen)ClO4] | 15,545 (646) | 0.044 | 1.85 |
| [Cu(DMIIMBP)(bipy)ClO4] | 16,323 (615) | 0.059 | 1.95 |
| [Cu(DMIIMBP)(oxine)] | 16,891 (592) | 0.061 | 1.92 |
| [Cu(DMIIMBP)(5-Cl-oxine)] | 15,954 (627) | 0.072 | 1.89 |
| [Cu(DMIIMCP)(phen)ClO4] | 15,210 (662) | 0.056 | 1.93 |
| [Cu(DMIIMCP)(bipy)ClO4] | 14,989 (665) | 0.063 | 1.89 |
| [Cu(DMIIMCP)(oxine)] | 16,273 (614) | 0.049 | 1.96 |
| [Cu(DMIIMCP)(5-Cl-oxine)] | 16,920 (591) | 0.045 | 1.87 |
ESR data of copper metal complexes 1–8.
| Compound | Temperature |
|
| Δ |
|
|---|---|---|---|---|---|
| [Cu(DMIIMBP)(phen)ClO4] | 300 K | 2.1539 | 2.0402 | 0.1137 | 3.8279 |
| [Cu(DMIIMBP)(bipy)ClO4] | 300 K | 2.1523 | 2.0536 | 0.0987 | 2.9238 |
| [Cu(DMIIMBP)(oxine)] | 300 K | 2.1510 | 2.0391 | 0.1119 | 3.8624 |
| [Cu(DMIIMBP)(5-Cl-oxine)] | 300 K | 2.1497 | 2.0411 | 0.1086 | 3.6437 |
| [Cu(DMIIMCP)(phen)ClO4] | 300 K | 2.1594 | 2.0431 | 0.1162 | 3.6928 |
| [Cu(DMIIMCP)(bipy)ClO4] | 300 K | 2.1710 | 2.0616 | 0.1093 | 2.841 |
| [Cu(DMIIMCP)(oxine)] | 300 K | 2.1498 | 2.0423 | 0.1075 | 3.5416 |
| [Cu(DMIIMCP)(5-Cl-oxine)] | 300 K | 2.1526 | 2.0426 | 0.1099 | 3.5807 |
Figure 2The ESR spectrum of [Cu(DMIIMBP)(phen)ClO4].
Figure 3(a) Interactions between TYR and LYS-DMIIMBP crystal ligand (yellow) and target protein (pale green). The TYR residue (gray) and LYS residue (pink) interactions are shown in CPK model. Hydrogen bonding interactions were represented as line (red). (b) Interactions between ASN-DMIIMCP crystal ligand (green) and target protein (pale green). The ASN residue (pink) interactions are shown in CPK model. Hydrogen bonding interactions were represented as line (red).
The energy values of the ligands DMIIMBP and DMIIMCP.
| Molecule | HOMO (eV) | LUMO (eV) | Binding energy (kcal/mol) | Total energy (kcal/mol) |
|---|---|---|---|---|
| DMIIMBP | −8.96 | −1.09 | −7.36 | −2959.70 |
| DMIIMCP | −8.89 | −1.06 | −7.49 | −2976.18 |
Figure 4(a) LUMO and HOMO structures for DMIIMBP. (b) LUMO and HOMO structures for DMIIMCP.
Antimicrobial activity of the Schiff bases and metal complexes.
| Complex |
|
|
|
|
|---|---|---|---|---|
| DMIIMBP | 17 | 14 | 11 | 8 |
| [Cu(DMIIMBP)(phen)ClO4] | 19 | 16 | 13 | 10 |
| [Cu(DMIIMBP)(bipy)ClO4] | 18 | 15 | 12 | 9 |
| [Cu(DMIIMBP)(oxine)] | 16 | 14 | 10 | 8 |
| [Cu(DMIIMBP)(5-Cl-oxine)] | 18 | 17 | 9 | 9 |
| DMIIMCP | 16 | 13 | 10 | 10 |
| [Cu(DMIIMCP)(phen)ClO4] | 17 | 16 | 11 | 12 |
| [Cu(DMIIMCP)(bipy)ClO4] | 18 | 15 | 11 | 11 |
| [Cu(DMIIMCP)(oxine)] | 15 | 14 | 8 | 8 |
| [Cu(DMIIMCP)(5-Cl-oxine)] | 16 | 15 | 9 | 10 |
| Ciprofloxacin | 20 | 18 | — | — |
| Ketoconazole | — | — | 15 | 13 |
In vitro cytotoxicity (HeLa cell line) of Cu (II) complexes.
| Concentration ( | Absorbance | Cell viability (%) | Toxicities (%) | Concentration ( | Absorbance | Cell viability (%) | Toxicities (%) |
|---|---|---|---|---|---|---|---|
| Control | 0.1165 | 100 | 0 | Control | 0.1165 | 100 | 0 |
| [Cu(DMIIMBP) | [Cu(DMIIMBP) | ||||||
| 2 | 0.1011 | 86.90 | 13.10 | 2 | 0.0800 | 68.66 | 31.34 |
| 4 | 0.0751 | 64.35 | 35.65 | 4 | 0.0625 | 53.64 | 46.36 |
| 6 | 0.0732 | 63.05 | 36.95 | 6 | 0.0534 | 45.83 | 54.17 |
| 8 | 0.0611 | 52.50 | 47.50 | 8 | 0.0502 | 43.09 | 56.91 |
| 10 | 0.0532 | 45.59 | 54.41 | 10 | 0.0495 | 42.49 | 57.51 |
| [Cu(DMIIMCP) | [Cu(DMIIMCP) | ||||||
| 2 | 0.0880 | 75.53 | 24.47 | 2 | 0.1120 | 96.13 | 3.87 |
| 4 | 0.0833 | 71.50 | 28.50 | 4 | 0.0985 | 84.54 | 15.46 |
| 6 | 0.0605 | 51.93 | 48.07 | 6 | 0.0726 | 62.31 | 37.69 |
| 8 | 0.0580 | 49.78 | 50.22 | 8 | 0.0696 | 59.74 | 40.26 |
| 10 | 0.0550 | 47.21 | 52.79 | 10 | 0.0580 | 49.78 | 50.22 |
Figure 5Percentage of cell viability versus different concentrations for HeLa cells exposed to the metal complexes after 72 h incubation.
IC50 range of Cu (II) complexes for HeLa cells.
| Complex | IC50 ( |
|---|---|
| [Cu(DMIIMBP)(phen)ClO4] | 9 ± 0.03 |
| [Cu(DMIIMBP)(bipy)ClO4] | 5 ± 0.06 |
| [Cu(DMIIMCP)(phen)ClO4] | 8 ± 0.03 |
| [Cu(DMIIMCP)(bipy)ClO4] | 10 ± 0.09 |
Figure 6Agarose gel electrophoresis patterns for the oxidative cleavage of pBR 322 DNA by 1 and 2(a) and photolytic cleavage of pBR 322 DNA by 1 and 2(b). (a) Lane 1, DNA control; Lane 2, DNA+1 (40 μM) + H2O2 (1 mM); Lane 3, DNA+1 (80 μM) + H2O2 (1 mM); Lane 4, DNA+1 (120 μM) + H2O2 (1 mM); Lane 5, DNA + H2O2 (1 mM) + DMSO (1 mM). Lane 6, DNA+2 (40 μM) + H2O2 (1 mM); Lane 7, DNA+2 (80 μM) + H2O2 (1 mM); Lane 8, DNA+2 (120 μM) + H2O2 (1 mM); (b) Lane 1, DNA control; Lane 2, DNA+1 (40 μM) + H2O2 (1 mM); Lane 3, DNA+1 (80 μM) + H2O2 (1 mM); Lane 4, DNA+1 (120 μM) + H2O2 (1 mM); Lane 5, DNA + DMSO (1 mM). Lane 6, DNA+2 (40 μM) + H2O2 (1 mM); Lane 7, DNA+2 (80 μM) + H2O2 (1 mM); Lane 8, DNA+2 (120 μM) + H2O2 (1 mM).
(a)
| S. number | Compound | Gold Fitness | S(hb_ext) | S(vdw_ext) | S(hb_int) | S(vdw_int) |
|---|---|---|---|---|---|---|
| 1 | DMIIMBP | 57.67 | 4.67 | 41.97 | 0.00 | −4.71 |
| 2 | DMIIMCP | 57.70 | 4.55 | 41.52 | 0.00 | −3.94 |
(b)
| S. number | Compound | Chem score | DG | S(hbond) | S(metal) | S(lipo) | DE(clash) | DE(int) |
|---|---|---|---|---|---|---|---|---|
| 1 | DMIIMBP | 19.16 | −19.44 | 1.88 | 0.00 | 87.41 | 0.03 | 0.25 |
| 2 | DMIIMCP | 19.03 | −19.23 | 1.90 | 0.00 | 85.10 | 0.01 | 0.18 |